@article{11b705601ded42139e84b05931ac95eb,
title = "COVID-19 and ovarian cancer: Exploring alternatives to intravenous (IV) therapies",
keywords = "COVID-19, Oral, Ovarian cancer, SARS-CoV-2, Targeted therapy",
author = "Monk, {Bradley J.} and Coleman, {Robert L.} and Moore, {Kathleen N.} and Herzog, {Thomas J.} and Secord, {Angeles Alvarez} and Matulonis, {Ursula A.} and Slomovitz, {Brian M.} and Guntupalli, {Saketh R.} and O'Malley, {David M.}",
note = "Funding Information: We thank A. Peter Morello III, Ph.D. (Clovis Oncology, Inc. Boulder, CO, USA) for assistance with preparation of this correspondence.",
year = "2020",
month = jul,
doi = "10.1016/j.ygyno.2020.04.703",
language = "English (US)",
volume = "158",
pages = "34--36",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "1",
}